Journal of Digestive Cancer Research

Korean Society of Gastrointestinal Cancer Research (대한소화기암연구학회)
권호 표지

A Case of Complete Remission after Palliative Chemotherapy and Salvage Radiotherapy for Lymph Node Recurrence in Advanced Gastric Cancer

근치적 절제술 후 림프절 재발이 발생한 진행성 위암에 대한 고식적 치료 1례

  • Jong Seok Joo (Division of Gastroenterology, Department of Internal Medicine, Chungnam National University School of Medicine) ;
  • Hyun Yong Jeong (Division of Gastroenterology, Department of Internal Medicine, Chungnam National University School of Medicine) ;
  • Hee Seok Moon (Division of Gastroenterology, Department of Internal Medicine, Chungnam National University School of Medicine) ;
  • Jae Kyu Sung (Division of Gastroenterology, Department of Internal Medicine, Chungnam National University School of Medicine) ;
  • Sun Hyung Kang (Division of Gastroenterology, Department of Internal Medicine, Chungnam National University School of Medicine)
  • 주종석 (충남대학교 의학전문대학원 내과학교실, 소화기내과) ;
  • 정현용 (충남대학교 의학전문대학원 내과학교실, 소화기내과) ;
  • 문희석 (충남대학교 의학전문대학원 내과학교실, 소화기내과) ;
  • 성재규 (충남대학교 의학전문대학원 내과학교실, 소화기내과) ;
  • 강선형 (충남대학교 의학전문대학원 내과학교실, 소화기내과)
  • Received : 2015.11.21
  • Accepted : 2015.12.17
  • Published : 2015.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

A 54-year-old male patient who was diagnosed with advanced gastric cancer underwent a distal gastrectomy, D2 lymph node dissection, and adjuvant chemoradiotherapy. After a year, in a follow-up PET-CT, lymph node metastases were observed in the neck and abdomen, and therefore, the patient underwent chemotherapy. After treatment, the follow-up PET-CT revealed a growth of the posterior neck lymph node. Thus, an excisional biopsy was performed, and the growth was diagnosed as metastatic adenocarcinoma. Therefore, the patient received chemotherapy with FOLFIRI. Another follow-up PET-CT after chemotherapy revealed a growth in the right inguinal lymph node, and the patient underwent salvage radiotherapy for this lesion. The PET-CT taken for the response evaluation showed no evidence of further metastasis of the lymph node. We hereby report a case of advanced gastric cancer with neck and inguinal lymph node recurrence showing complete remission after palliative chemotherapy and salvage radiotherapy.

위암의 재발은 환자의 예후를 불량하게 하며, 재발성 위암의 치료 방법은 재발 양상에 따라서 달라질 수 있고, 국내외적으로 항암치료를 제외한 치료 방법에 대해 뚜렷한 지침이 정해져 있지는 않다. 저자들은 근치적 위절제술 시행 후 림프절 전이가 발생한 진행성 위암 환자에서 고식적 항암화학치료와 구제 방사선요법을 시행한 뒤 완전 관해에 도달한 증례를 경험하였기에 문헌 고찰과 함께 보고하는 바이다.

Keywords

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
  2. National Cancer Information Center. National statistics of cancer registration 2012 [Internet]. Goyang: National Cancer Infermation Center. Available from: http://www.cancer.go.kr/ebook/104/PC/104.html.
  3. Park SR, Kang YK. Perioperative treatments for resectable gastric cancer. J Korean Med Assoc 2015;58:201-218.
  4. Kim TY, Oh DY, Bang YJ. Treatment for unresectable gastric cancer. J Korean Med Assoc 2015;58:209-215.
  5. Ahn JS, Ryu SW, Kim IH, Sohn SS. Clinicopathological Analysis of Recurrent Gastric Cancer after Curative Resection. J Korean Surg Soc 2003;65:210-216.
  6. Iwanaga T, Koyama H, Furukawa H, Taniguch H, Wada A, Tatelshi R. Mechanisms of late recurrence after radical surgery for gastric carcinoma. Am J Surg 1978;135:637-640.
  7. Koga S, Takebayashi M, Kaibara N, et al. Pathological characteristics of gastric cancer that develop hematogenous recurrence, with special reference to the site of recurrence. J Surg Oncol 1987;36:239-242.
  8. Papachristou DN, Fortner JG. Local recurrence of gastric adenocarcinomas after gastrectomy. J Surg Oncol 1981;18:47-53.
  9. Lee HJ, Cho SJ, Yang HK, Lee KU, Choe KJ, Kim JP. Retrospective analysis of treatment results of recurrent gastric cancer. J Korean Cancer Assoc 2000;32:506-515.
  10. Bamias A, Pavlidis N. Systemic Chemotherapy in Gastric Cancer: Where Do We Stand Today? Oncologist 1998;3:171-177.
  11. Kang YK, Kang WK, Shin DB et al. Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial. Ann Oncol. 2009;20:666-673.
  12. Koizumi W, Narahara H, Hara T, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 2008;9:215-221.
  13. Cunningham D, Okines AF, Ashley S. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 2010;362:858-859.
  14. Park JM, Kim YH. Current approaches to gastric cancer in Korea. Gastrointestinal cancer research: GCR. 2008;2:137.
  15. Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastrooesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376:687-697.
  16. Kang JH, Lee SI, Lim DH, et al. Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone. J Clin Oncol 2012;30:1513-1518.
  17. Thuss-Patience PC, Kretzschmar A, Bichev D, et al. Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer--a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Eur J Cancer 2011;47:2306-2314.
  18. Lee JH, Kim JG, Jung HK, et al. [Synopsis on clinical practice guideline of gastric cancer in Korea: an evidence-based approach]. Korean J Gastroenterol 2014;63:66-81.
  19. Kim BH, Eom KY, Kim JS, Kim HH, Park DJ. Role of salvage radiotherapy for regional lymph node recurrence after radical surgery in advanced gastric cancer. Radiat Oncol J 2013;31:147-154.